Search Results

Antineoplastic Chemotherapy Induced QTc Prolongation

Authors: Bagnes, Claudia; Panchuk, Patricia N.; Recondo, Gonzalo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 93-96(4)

Publisher: Bentham Science Publishers

Allergic reactions to docetaxel vary between chemotherapy regimens

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 3-3(1)

Publisher: Adis International

Docetaxel: Persistent serpentine supravenous hyperpigmented eruption: case report

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 18-18(1)

Publisher: Adis International

Anthracycline/docetaxel regimens come at a cost

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 12-12(1)

Publisher: Adis International

The Predictive Role of E-cadherin and Androgen Receptor on In Vitro Chemosensitivity in Triple-negative Breast Cancer

Authors: Koo, Ja Seung; Jung, Woohee; Jeong, Joon

Source: Japanese Journal of Clinical Oncology, Volume 39, Number 9, 11 September 2009 , pp. 560-568(9)

Publisher: Oxford University Press

Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel

Authors: Sekine, I.; Ichinose, Y.; Nishiwaki, Y.; Yamamoto, N.; Tsuboi, M.; Nakagawa, K.; Shinkai, T.; Negoro, S.; Imamura, F.; Eguchi, K.; Takeda, K.; Itoh, Y.; Tamura, T.; Saijo, N.; Fukuoka, M.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1483-1488(6)

Publisher: Oxford University Press

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

Authors: Ruhstaller, T.; Widmer, L.; Schuller, J. C.; Roth, A.; Hess, V.; Mingrone, W.; von Moos, R.; Borner, M.; Pestalozzi, B. C.; BalmerMajno, S.; Kberle, D.; Terraciano, L.; Schnider, A.; Bodis, S.; Popescu, R.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1522-1528(7)

Publisher: Oxford University Press

Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment

Authors: Müller, Sebastian; Holzapfel, Korbinian; Seidl, Christof; Treiber, Uwe; Krause, Bernd; Senekowitsch-Schmidtke, Reingard

Source: European Journal of Nuclear Medicine and Molecular Imaging, Volume 36, Number 9, September 2009 , pp. 1434-1442(9)

Publisher: Springer

Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer

Authors: Zang, Dae; Yang, Dae; Kim, Min-Jeong; Jang, Kyung; Hwang, Se; Yoo, Kyo-Sang; Han, Taeho; Kim, Ho; Kim, Hyo; Kwon, Jung; Song, Hun; Park, Sarah; Jung, Joo; Kim, Hyeong; Kim, Jung

Source: Cancer Chemotherapy and Pharmacology, Volume 64, Number 5, October 2009 , pp. 877-883(7)

Publisher: Springer

Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents

Authors: Kurtzberg, Leslie; Roth, Stephanie; Bagley, Rebecca; Rouleau, Cecile; Yao, Min; Crawford, Jennifer; Krumbholz, Roy; Schmid, Steven; Teicher, Beverly

Source: Cancer Chemotherapy and Pharmacology, Volume 64, Number 5, October 2009 , pp. 1029-1038(10)

Publisher: Springer

Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents

Authors: Takeshita, Takashi; Wu, Wenwen; Koike, Ayaka; Fukuda, Mamoru; Ohta, Tomohiko

Source: Cancer Chemotherapy and Pharmacology, Volume 64, Number 5, October 2009 , pp. 1039-1046(8)

Publisher: Springer

Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer

Authors: Schwartzberg, Lee; Cobb, Patrick; Walker, Mark; Stepanski, Edward; Houts, Arthur

Source: Supportive Care in Cancer, Volume 17, Number 8, August 2009 , pp. 1081-1088(8)

Publisher: Springer

Gefitinib: A Review of its Use in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer

Authors: Sanford, Mark; Scott, Lesley J.

Source: Drugs, Volume 69, Number 16, 12 November 2009 , pp. 2303-2328(26)

Publisher: Adis International

Editorial [Hot topic: Prostate Cancer Therapy (Guest Editors: N. Sharifi and J.B. Aragon-Ching)]

Authors: Sharifi, N.; Aragon-Ching, J. B.

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 9, Number 10, December 2009 , pp. 1039-1039(1)

Publisher: Bentham Science Publishers

Cytotoxic Compounds in the Treatment of Castration-Resistant Prostate Cancer

Authors: Lee, Patrick; Aragon-Ching, Jeanny B.

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 9, Number 10, December 2009 , pp. 1040-1045(6)

Publisher: Bentham Science Publishers

Angiogenesis Inhibition in the Treatment of Prostate Cancer

Authors: Madan, Ravi A.; Dahut, William L.

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 9, Number 10, December 2009 , pp. 1070-1078(9)

Publisher: Bentham Science Publishers

Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers

Authors: Li, Xiang; Wang, Dongkai; Zhang, Jing; Pan, Weisan

Source: Journal of Pharmacy and Pharmacology, Volume 61, Number 11, November 2009 , pp. 1485-1492(8)

Publisher: Pharmaceutical Press

Weekly Administration of Docetaxel and Epirubicin as First-Line Treatment for Hormone-Refractory Prostate Carcinoma

Authors: Neri, B.; Molinara, E.; Pantaleo, P.; Rangan, S.; Crisci, A.; Della Melina, A.; Raugei, A.; Villari, D.; Nicita, G.

Source: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 17, Numbers 11-12, 2009 , pp. 565-570(6)

Publisher: Cognizant Communication Corporation

Antineoplastics: Osteonecrosis and osteomyelitis (first report with epirubicin): case report

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 6-6(1)

Publisher: Adis International

Is There a Place for Drug Combination Strategies Using Clinical Pharmacology Attributes? - Review of Current Trends in Research

Author: Srinivas, Nuggehally R.

Source: Current Clinical Pharmacology, Volume 4, Number 3, September 2009 , pp. 220-228(9)

Publisher: Bentham Science Publishers